Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders?

Stepan, Jens; Anderzhanova, Elmira; Gassen, Nils C.

doi:10.3389/fpsyt.2018.00715

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders?

MPS-Authors

/persons/resource/persons80544

Stepan, Jens
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

fpsyt-09-00715.pdf
(出版社版), 742KB

付随資料 (公開)

There is no public supplementary material available

引用

Stepan, J., Anderzhanova, E., & Gassen, N. C. (2018). Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders? FRONTIERS IN PSYCHIATRY, 9:. doi:10.3389/fpsyt.2018.00715.

引用: https://hdl.handle.net/21.11116/0000-0003-924A-5

要旨

Discovery of the Hippo pathway and its core components has made a significant impact on our progress in the understanding of organ development, tissue homeostasis, and regeneration. Upon diverse extracellular and intracellular stimuli, Hippo signaling regulates stemness, cell proliferation and apoptosis by a well-conserved signaling cascade, and disruption of these systems has been implicated in cancer as well as metabolic and neurodegenerative diseases. The central role of Hippo signaling in cell biology also results in prominent links to stress-regulated pathways. Genetic variations, epigenetically provoked upregulation of Hippo pathway members and dysregulation of cellular processes implicated in learning and memory, are linked to an increased risk of stress-related psychiatric disorders (SRPDs). In this review, we summarize recent findings, supporting the role of Hippo signaling in SRPDs by canonical and non-canonical Hippo pathway interactions.